Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Morepen Laboratories Limited (MOREPENLAB) Stock Price & Analysis

14 Followers

MOREPENLAB Stock Chart & Stats

₹99.75₹4.75(5.00%)
At close: 3:30 PM GMT+5:30
₹80₹100₹120₹140Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 94.00 - INR 99.75
52-Week Range
INR 33.42 - INR 150.80
Previous Close
INR 95.00
Volume
N/A
Average Volume (3M)
592.85K
Market Cap
INR 52.06B
Enterprise Value
INR 69.57B
Total Cash (Recent Filing)
INR 2.71B
Total Debt (Recent Filing)
INR 3.23B
Price to Earnings (P/E)
29.0
Beta
0.85
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 18, 2026
Dividend Yield
0.20%

Bulls Say, Bears Say

Bulls Say

Revenue Expansion

Meaningful multi-year revenue growth indicates that Morepen is expanding its customer reach across APIs and finished dosage products. Continued top-line development can support operating leverage, strengthen market presence, and provide a durable base for earnings growth over the next several quarters.

Improved Profitability

The recovery from the 2023 earnings trough and sustained positive net income show that the business has regained profitability. A healthier earnings base improves internal funding capacity and gives management more flexibility to reinvest in products, manufacturing, and distribution.

Equity-Supported Balance Sheet

A growing equity base and moderate leverage provide financial resilience for a pharmaceutical manufacturer operating across domestic and international markets. This structure can reduce dependence on external financing and preserve capacity to fund expansion despite some recent debt growth.

Bears Say

Persistent Free Cash Flow Deficit

Persistent negative free cash flow means reported profits are not yet translating into sufficient surplus cash. Continued cash burn can constrain investment, increase reliance on borrowing or other funding, and weaken the company’s ability to absorb operational volatility.

Margin Compression

Recent margin compression reduces the quality and durability of the company’s earnings recovery. If lower margins persist, revenue growth will generate less profit and cash, limiting operating leverage and making future performance more sensitive to costs and pricing conditions.

Higher Debt And Lower Returns

The increase in debt reduces balance-sheet flexibility compared with prior years, while declining return on equity indicates less efficient use of shareholder capital. Together, these trends can limit funding flexibility and weaken the quality of future earnings growth.

Morepen Laboratories Limited News

MOREPENLAB FAQ

What was Morepen Laboratories Limited’s price range in the past 12 months?
Morepen Laboratories Limited lowest stock price was ₹33.42 and its highest was ₹150.80 in the past 12 months.
What is Morepen Laboratories Limited’s market cap?
Morepen Laboratories Limited’s market cap is ₹52.06B.
When is Morepen Laboratories Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Morepen Laboratories Limited’s earnings last quarter?
Morepen Laboratories Limited released its earnings results on Oct 27, 2026. The company reported ₹1.622 earnings per share for the quarter.
Is Morepen Laboratories Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Morepen Laboratories Limited pay dividends?
Morepen Laboratories Limited pays an annual dividend of ₹0.2 which represents an annual dividend yield of 0.2%. See more information on Morepen Laboratories Limited dividends here
What is Morepen Laboratories Limited’s EPS estimate?
Morepen Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Morepen Laboratories Limited have?
Morepen Laboratories Limited has 547,953,700 shares outstanding.
What happened to Morepen Laboratories Limited’s price movement after its last earnings report?
Morepen Laboratories Limited reported an EPS of ₹1.622 in its last earnings report. Following the earnings report the stock price went up 4.826%.
Which hedge fund is a major shareholder of Morepen Laboratories Limited?
Currently, no hedge funds are holding shares in IN:MOREPENLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology